Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 37% ± 17% | |
peripheral blood | 15 studies | 30% ± 9% | |
intestine | 10 studies | 32% ± 19% | |
kidney | 8 studies | 34% ± 12% | |
eye | 7 studies | 27% ± 12% | |
bone marrow | 5 studies | 25% ± 7% | |
brain | 5 studies | 29% ± 10% | |
liver | 5 studies | 32% ± 24% | |
lymph node | 5 studies | 38% ± 13% | |
pancreas | 4 studies | 41% ± 18% | |
uterus | 4 studies | 42% ± 14% | |
breast | 4 studies | 30% ± 7% | |
placenta | 3 studies | 35% ± 23% | |
adrenal gland | 3 studies | 29% ± 10% | |
prostate | 3 studies | 20% ± 4% | |
skin | 3 studies | 21% ± 2% | |
thymus | 3 studies | 56% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4898.35 | 258 / 258 | 100% | 193.13 | 230 / 230 |
esophagus | 100% | 4125.72 | 1445 / 1445 | 100% | 227.72 | 183 / 183 |
ovary | 100% | 5129.41 | 180 / 180 | 100% | 496.63 | 430 / 430 |
thymus | 100% | 4401.58 | 653 / 653 | 100% | 334.73 | 605 / 605 |
uterus | 100% | 5391.47 | 170 / 170 | 100% | 363.83 | 459 / 459 |
skin | 100% | 4214.09 | 1807 / 1809 | 100% | 278.60 | 472 / 472 |
brain | 100% | 3634.66 | 2637 / 2642 | 100% | 295.65 | 705 / 705 |
liver | 100% | 2727.54 | 225 / 226 | 100% | 200.04 | 406 / 406 |
prostate | 100% | 4601.95 | 245 / 245 | 99% | 274.71 | 499 / 502 |
intestine | 100% | 4181.79 | 966 / 966 | 99% | 247.04 | 523 / 527 |
stomach | 100% | 2983.52 | 359 / 359 | 99% | 240.02 | 283 / 286 |
kidney | 100% | 3969.06 | 89 / 89 | 99% | 176.67 | 891 / 901 |
pancreas | 100% | 2271.63 | 327 / 328 | 99% | 223.06 | 176 / 178 |
lung | 100% | 3376.79 | 576 / 578 | 99% | 273.10 | 1139 / 1155 |
bladder | 100% | 4870.38 | 21 / 21 | 98% | 312.52 | 495 / 504 |
breast | 100% | 3781.12 | 459 / 459 | 98% | 297.89 | 1098 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 268.46 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 440.31 | 29 / 29 |
muscle | 100% | 6720.38 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3672.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 286.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 444.52 | 1 / 1 |
adipose | 100% | 3506.13 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5520.03 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4152.61 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 2803.61 | 869 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0015074 | Biological process | DNA integration |
GO_0009615 | Biological process | response to virus |
GO_0160049 | Biological process | negative regulation of cGAS/STING signaling pathway |
GO_0010836 | Biological process | negative regulation of protein ADP-ribosylation |
GO_0032480 | Biological process | negative regulation of type I interferon production |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0051276 | Biological process | chromosome organization |
GO_0007084 | Biological process | mitotic nuclear membrane reassembly |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000793 | Cellular component | condensed chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BANF1 |
Protein name | Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed] BAF nuclear assembly factor 1 |
Synonyms | BAF BCRG1 |
Description | FUNCTION: Non-specific DNA-binding protein that plays key roles in mitotic nuclear reassembly, chromatin organization, DNA damage response, gene expression and intrinsic immunity against foreign DNA . Contains two non-specific double-stranded DNA (dsDNA)-binding sites which promote DNA cross-bridging . Plays a key role in nuclear membrane reformation at the end of mitosis by driving formation of a single nucleus in a spindle-independent manner . Transiently cross-bridges anaphase chromosomes via its ability to bridge distant DNA sites, leading to the formation of a dense chromatin network at the chromosome ensemble surface that limits membranes to the surface . Also acts as a negative regulator of innate immune activation by restricting CGAS activity toward self-DNA upon acute loss of nuclear membrane integrity . Outcompetes CGAS for DNA-binding, thereby preventing CGAS activation and subsequent damaging autoinflammatory responses . Also involved in DNA damage response: interacts with PARP1 in response to oxidative stress, thereby inhibiting the ADP-ribosyltransferase activity of PARP1 . Involved in the recognition of exogenous dsDNA in the cytosol: associates with exogenous dsDNA immediately after its appearance in the cytosol at endosome breakdown and is required to avoid autophagy . In case of poxvirus infection, has an antiviral activity by blocking viral DNA replication . .; FUNCTION: (Microbial infection) Exploited by retroviruses for inhibiting self-destructing autointegration of retroviral DNA, thereby promoting integration of viral DNA into the host chromosome . EMD and BAF are cooperative cofactors of HIV-1 infection . Association of EMD with the viral DNA requires the presence of BAF and viral integrase . The association of viral DNA with chromatin requires the presence of BAF and EMD . . |
Accessions | ENST00000312175.7 ENST00000530204.1 ENST00000445560.6 ENST00000527348.1 E9PJJ8 ENST00000533166.5 O75531 |